These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33843131)

  • 1. Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.
    Voll AM; Meyners C; Taubert MC; Bajaj T; Heymann T; Merz S; Charalampidou A; Kolos J; Purder PL; Geiger TM; Wessig P; Gassen NC; Bracher A; Hausch F
    Angew Chem Int Ed Engl; 2021 Jun; 60(24):13257-13263. PubMed ID: 33843131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.
    Bauder M; Meyners C; Purder PL; Merz S; Sugiarto WO; Voll AM; Heymann T; Hausch F
    J Med Chem; 2021 Mar; 64(6):3320-3349. PubMed ID: 33666419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity.
    Shi D; Bai Q; Zhou S; Liu X; Liu H; Yao X
    Proteins; 2018 Jan; 86(1):43-56. PubMed ID: 29023988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the N-terminal domain of human FKBP52.
    Li P; Ding Y; Wu B; Shu C; Shen B; Rao Z
    Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):16-22. PubMed ID: 12499534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBPs and their role in neuronal signaling.
    Hausch F
    Biochim Biophys Acta; 2015 Oct; 1850(10):2035-40. PubMed ID: 25615537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP52.
    Davies TH; Sánchez ER
    Int J Biochem Cell Biol; 2005 Jan; 37(1):42-7. PubMed ID: 15381148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.
    Li TK; Baksh S; Cristillo AD; Bierer BE
    J Cell Biochem; 2002; 84(3):460-71. PubMed ID: 11813252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52.
    Mustafi SM; LeMaster DM; Hernández G
    Biochem J; 2014 Jul; 461(1):115-23. PubMed ID: 24749623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
    Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
    J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
    Davies TH; Ning YM; Sánchez ER
    Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of NanoBRET-Binding Assays for FKBP-Ligand Profiling in Living Cells.
    Gnatzy MT; Geiger TM; Kuehn A; Gutfreund N; Walz M; Kolos JM; Hausch F
    Chembiochem; 2021 Jul; 22(13):2257-2261. PubMed ID: 33887102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Decalin-Based Bicyclic Scaffold for FKBP51-Selective Ligands.
    Feng X; Sippel C; Knaup FH; Bracher A; Staibano S; Romano MF; Hausch F
    J Med Chem; 2020 Jan; 63(1):231-240. PubMed ID: 31800244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP51 and FKBP12.6-Novel and tight interactors of Glomulin.
    Hähle A; Geiger TM; Merz S; Meyners C; Tianqi M; Kolos J; Hausch F
    PLoS One; 2019; 14(9):e0221926. PubMed ID: 31490997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large FK506-binding proteins shape the pharmacology of rapamycin.
    März AM; Fabian AK; Kozany C; Bracher A; Hausch F
    Mol Cell Biol; 2013 Apr; 33(7):1357-67. PubMed ID: 23358420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical allosteric coupling to the active site indole ring flip equilibria in the FK506-binding domain.
    Anderson JS; Mustafi SM; Hernández G; LeMaster DM
    Biophys Chem; 2014 Aug; 192():41-8. PubMed ID: 25016286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The full electron structure of the FKBP12/FK506 complex.
    Rossetto AM; Zhou W; Pang X; Zhou L
    J Biomol Struct Dyn; 2015; 33(2):388-94. PubMed ID: 24471694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.
    Gopalakrishnan R; Kozany C; Gaali S; Kress C; Hoogeland B; Bracher A; Hausch F
    J Med Chem; 2012 May; 55(9):4114-22. PubMed ID: 22455444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.
    Sinars CR; Cheung-Flynn J; Rimerman RA; Scammell JG; Smith DF; Clardy J
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):868-73. PubMed ID: 12538866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Discovery of a New Selectivity-Enabling Motif for the FK506-Binding Protein 51.
    Knaup FH; Meyners C; Sugiarto WO; Wedel S; Springer M; Walz C; Geiger TM; Schmidt M; Sisignano M; Hausch F
    J Med Chem; 2023 Apr; 66(8):5965-5980. PubMed ID: 37058391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.